Abstract
Although much progress has been made in new drug development, it is still a costly, complicated and less efficient process. Therefore, drug repositioning studies are highly desirable. So far, many methods based on known drug-target interactions (DTIs) have been designed to detect potential DTIs, but there are many challenges for improving the performance of prediction DTIs. This paper proposes a new method (CaGCN-DTI) for DTIs prediction, which uses a heterogeneous network that incorporates a wide variety of biological data (drug, target, disease, and side effect) to discover potential interactions between drugs and targets. First, the drug-protein similarity network is preprocessed by Spectral clustering, then the graph convolutional network (GCN) combined with attention mechanism and random walk with restart (RWR) is used to aggregate message transmission to the network. Finally, the embedding vectors are used to discover potential DTIs by matrix decomposition. Experiments are performed based on ten-fold cross-validation, and the results show that CaGCN-DTI outperforms other previous methods in terms of AUC and AUPR.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
